insights_auto
Why is AXGN up 2.61%?
Dive Deeperchevron_right
AXGN:NASDAQ
AxoGen, Inc Common Stock
$50.02
arrow_upward
+2.61%(+1.27) 1D
$50.00
arrow_downward
-0.04% (-0.020)bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXGN...
Open
$48.55
High
$50.29
Low
$48.14
Mkt. cap
2.99B
Avg. vol.
1.79M
Volume
1.67M
52-wk high
$52.91
52-wk low
$23.00
EPS
-$0.68
Beta
1.21
Shares outstanding
59.73M
No. of employees
622
Open
$48.55
High
$50.29
Low
$48.14
Mkt. cap
2.99B
Avg. vol.
1.79M
Volume
1.67M
52-wk high
$52.91
52-wk low
$23.00
EPS
-$0.68
Beta
1.21
Shares outstanding
59.73M
No. of employees
622
News stories
From web sources and news partners
www.tmgm.com
·
13 hours ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
富途牛牛
·
2 hours ago
JPMorgan: The momentum crash is a mid-cycle correction within the AI supercycle; maintains S&P 500 target at 8,000 points.
BigGo Finance
·
12 hours ago
Dow Falls Another 237 Points; AI Stocks Rebound but Rate-Hike Expectations Weigh
Investing.com
·
13 hours ago
S&P cuts Uganda outlook to stable on oil delays and widening fiscal deficit
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersAlachua, Florida, United States
SectorHealth Care
IndustryMedical device
Websiteaxogeninc.com